allergic reaction to semaglutide Exploring Semaglutide-Induced Rash: Causes, Prevention, and Treatment TrimRX | Semaglutide Injection Site

For context, semaglutide 2.4 mg (Wegovy) demonstrated approximately 15% mean weight loss in the STEP 1 trial ( NEJM , 2021), while tirzepatide achieved up to approximately 22% in the SURMOUNT-1 trial ( NEJM , 2022)

All authors have reviewed the submitted version and agreed to publish the manuscript

Lancet Diabetes Endocrinol 7(5):385396

Clinical studies, including the STEP 1 extension trial, have demonstrated that patients who discontinue GLP-1 receptor agonists often regain a significant portion of lost weightsometimes two-thirds or morewithin one year of stopping treatment

While moderate alcohol can fit into some lifestyles, reducing how often and how much you drink may better support GLP-1 for weight loss and healthier eating habits